Skip to main content
Fig. 6 | BMC Genomics

Fig. 6

From: Identification of an individualized therapy prognostic signature for head and neck squamous cell carcinoma

Fig. 6

Validation of the prognostic risk model in the TCGA-HNSC cohort (training set) and GSE65858 cohort (validation set). A, D Survival curves for HNSCC patients with high- and the low-risk score. B, E Survival status of patients with high- and the low-risk score. C, F Receiver operating characteristic (ROC) curves for 1-, 3- and 5-year overall survival in HNSCC patients. Up panels are TCGA-HNSC cohort and lower panels are GSE65858 cohort

Back to article page

BMC Genomics

ISSN: 1471-2164

Contact us